Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
本文描述了式(A)的化合物,其药学上可接受的盐以及药物组合物。本发明的化合物对抑制PR
MT5活性是有用的。还描述了利用这些化合物治疗PR
MT5介导的疾病的方法。